newsfilter
← Latest News
Business Wire·

Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

-- Q1 2023 net sales of $15.6 million, an increase of 54% compared to Q4 2022 -- -- Company to be acquired by Assertio Holdings, Inc., delivering value to stakeholders in an all stock and contingent value rights (CVR)